RhumbLine Advisers’s Privia Health PRVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.34M | Buy |
319,160
+24,807
| +8% | +$571K | 0.01% | 1207 |
|
|
2025
Q1 | $6.61M | Buy |
294,353
+7,153
| +2% | +$161K | 0.01% | 1218 |
|
|
2024
Q4 | $5.61M | Buy |
287,200
+3,658
| +1% | +$71.5K | 0.01% | 1368 |
|
|
2024
Q3 | $5.16M | Sell |
283,542
-12,304
| -4% | -$224K | ﹤0.01% | 1409 |
|
|
2024
Q2 | $5.14M | Sell |
295,846
-5,394
| -2% | -$93.7K | ﹤0.01% | 1383 |
|
|
2024
Q1 | $5.9M | Buy |
301,240
+3,659
| +1% | +$71.7K | 0.01% | 1322 |
|
|
2023
Q4 | $6.85M | Buy |
297,581
+8,919
| +3% | +$205K | 0.01% | 1241 |
|
|
2023
Q3 | $6.64M | Buy |
288,662
+57,669
| +25% | +$1.33M | 0.01% | 1198 |
|
|
2023
Q2 | $6.03M | Buy |
230,993
+167,004
| +261% | +$4.36M | 0.01% | 1271 |
|
|
2023
Q1 | $1.77M | Buy |
63,989
+4,704
| +8% | +$130K | ﹤0.01% | 1871 |
|
|
2022
Q4 | $1.35M | Buy |
59,285
+2,797
| +5% | +$63.5K | ﹤0.01% | 1993 |
|
|
2022
Q3 | $1.92M | Buy |
56,488
+6,143
| +12% | +$209K | ﹤0.01% | 1786 |
|
|
2022
Q2 | $1.47M | Buy |
50,345
+13,472
| +37% | +$392K | ﹤0.01% | 1936 |
|
|
2022
Q1 | $986K | Buy |
36,873
+20,464
| +125% | +$547K | ﹤0.01% | 2137 |
|
|
2021
Q4 | $425K | Sell |
16,409
-724
| -4% | -$18.8K | ﹤0.01% | 2577 |
|
|
2021
Q3 | $404K | Buy |
17,133
+940
| +6% | +$22.2K | ﹤0.01% | 2640 |
|
|
2021
Q2 | $718K | Buy |
+16,193
| New | +$718K | ﹤0.01% | 2395 |
|